martes, 4 de septiembre de 2012

IMS diversifica...PharmaDeals & TTC




IMS Health has acquired PharmaDeals, the UK-based subsidiary of PharmaVentures, which specialises in storing online information about business transactions, licensing, and mergers and acquisitions activity within the global pharmaceutical industry.

Through the deal PharmaDeals will become part of IMS’s syndicated analytics and insights operation, helping healthcare clients with their real-time decision making in the areas of market assessment, forecasting and lifecycle and portfolio management. PharmaDeals maintains a web-based subscription database containing 46,000 records of industry transactions and 16 years of historical data. (Más)



PARSIPPANY, NJ, August 15, 2012 – IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools to enhance the speed, efficiency and cost-effectiveness of their trial planning and management activities.

IMS will integrate its evidence-based, anonymized patient and treatment outcomes insights with TTC’s comprehensive cost data drawn from organizations that conduct nearly 80 percent of all commercial clinical studies. TTC maintains GrantPlan®, the world’s largest clinical grant benchmarking and negotiation database, and serves 17 of the top 20 pharmaceutical companies and eight of the ten largest Contract Research Organizations. This follows IMS’s April 2012 acquisition of DecisionView, a technology innovator that delivers clinical trial planning and performance solutions. The combination will enable pharma R&D teams to significantly improve the productivity of their clinical trials through unprecedented access to advanced analytics and decision-support tools. (Más)

Publicar un comentario